Emma Guttman-Yassky MD
Waldman Professor of Dermatology and Immunology and Health System Chair, Department of Dermatology, Icahn School of Medicine at Mount Sinai
Request Appointment
5 east 98th streetNew York, NY 10029
Overview of Dr. Guttman-Yassky
Dr. Emma Guttman-Yassky is a dermatologist in New York, NY and is affiliated with The Mount Sinai Hospital. She received her medical degree from Tel Aviv University Sackler and has been in practice 23 years. She is one of 342 doctors at The Mount Sinai Hospital who specialize in Dermatology. She has more than 100 publications and over 500 citings.
Education & Training
Tel Aviv University SacklerClass of 1998
Certifications & Licensure
FL State Medical License 2020 - Present
NY State Medical License 2007 - 2027
American Board of Dermatology Dermatology
Clinical Trials
- The Efficacy and Safety of Secukinumab in Patients With Ichthyoses Start of enrollment: 2016 Dec 01
Publications & Presentations
PubMed
- Rapid Itch Improvement and Skin Clearance with Upadacitinib Versus Placebo (Measure Up 1 and Measure Up 2) and Versus Dupilumab (Heads Up): Results from Three Phase 3 ...Eric L Simpson, Jonathan I Silverberg, Vimal H Prajapati, Kilian Eyerich, Norito Katoh
Dermatology and Therapy. 2025-06-02 - Tape-strip profiling identifies unique immune and lipid dysregulation in patients with seborrheic dermatitis.Benjamin Ungar, Meredith Manson, Madeline Kim, Digpal Gour, Panipak Temboonnark
Journal of the American Academy of Dermatology. 2025-06-01 - 1 citationsOrismilast, a phosphodiesterase 4B/D inhibitor, in moderate-to-severe atopic dermatitis: efficacy and safety from a multicentre randomized placebo-controlled phase IIb...Jonathan I Silverberg, Lawrence F Eichenfield, Andrew Blauvelt, Alan D Irvine, Emma Guttman-Yassky
The British Journal of Dermatology. 2025-05-19
Press Mentions
Mount Sinai Dermatologists Use Tape Strips to Map Immune Changes in Common Skin DiseaseJune 10th, 2025- Ritlecitinib plus nbUVB Phototherapy Improves Repigmentation in Nonsegmental Vitiligo in a Phase 2b Extension StudyApril 30th, 2025
- Phototherapy Promising as Add-on to Oral Ritlecitinib for VitiligoApril 18th, 2025
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
